Overview

Sitosterolemia Extension Study (0653-003)(COMPLETED)

Status:
Completed
Trial end date:
2004-11-30
Target enrollment:
0
Participant gender:
All
Summary
This is an extension study for patients having unusually high absorption of non-cholesterol sterols, resulting in heart-related diseases. This study will evaluate the long term safety and the ability to lower cholesterol levels with an investigational drug.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Merck Sharp & Dohme Corp.
Treatments:
Ezetimibe
Criteria
Inclusion Criteria:

- Patients with elevated sitosterol levels while taking current medication

Exclusion Criteria:

- Patient has a condition which, in the opinion of the investigator, might pose a risk
to the patient, interfere with participation in the study, or does not meet the
additional criteria as required by the study.